Cytoreductive Surgery in Ovarian Cancer

Cancer Imaging - United Kingdom
doi 10.1102/1470-7330.2007.0030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

E-MED LTD

Related search

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

Cancer Control
MedicineOncologyHematology
1996English

Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer

JAMA Oncology
Cancer ResearchOncology
2017English

A Preoperative Personalized Risk Assessment Calculator for Elderly Ovarian Cancer Patients Undergoing Primary Cytoreductive Surgery

Gynecologic Oncology
GynecologyOncologyObstetrics
2015English

Improved Postoperative Pain Control for Cytoreductive Surgery in Women With Ovarian Cancer Using Patient-Controlled Epidural Analgesia

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2016English

Surgery in Recurrent Ovarian Cancer

Cancer
Cancer ResearchOncology
2019English

A Pre-Operative Predictive Score to Evaluate the Feasibility of Complete Cytoreductive Surgery in Patients With Epithelial Ovarian Cancer

PLoS ONE
Multidisciplinary
2017English

Secondary Cytoreductive Surgery for Recurrent Epithelial Ovarian Carcinoma: Proposal for Patients Selection

British Journal of Cancer
Cancer ResearchOncology
2005English

Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients With a High Tumor Burden: Variations in Practice and Impact on Outcome

Annals of Surgical Oncology
OncologySurgery
2019English

Erratum To: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer

Annals of Surgical Oncology
OncologySurgery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy